Protara Therapeutics Announces FDA Clearance of Investigational New Drug Application for TARA-002 for the Treatment of Non-Muscle Invasive Bladder Cancer

Matt Turner
Patient Affordability

Brenda Snow
Authentic Patient Voice

Matthew Durham
Omnidynamic Marketing

Bud Bilanich
Success Coach

Liz Kane
Impactful Strategy

Amy Giles
Increasing Engagement

Stacey Gandler
Brand Nourishment

Pat Purcell
Meeting Engagement

Joey Cohen
Medication Adherence

Suma Ramadas, PhD
Medical Affairs

David Linetsky
Point-of-Care Marketing

Paul Theisen
Patient Acquisition

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access